Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Finetti

Showing results (21-30 of 180) with videos related to

Pageof 18
Sort By:
International Journal of Cancer|April 10, 2008
How basal are triple-negative breast cancers?François Bertucci, Pascal Finetti, Nathalie Cervera, et al.
Cancers|September 5, 2020
Revisiting the Concept of Stress in the Prognosis of Solid Tumors: A Role for Stress Granules Proteins?Anaïs Aulas, Pascal Finetti, Shawn M Lyons, et al.
Oncoimmunology|July 9, 2015
PDL1 expression is an independent prognostic factor in localized GISTFrançois Bertucci, Pascal Finetti, Emilie Mamessier, et al.
Cancer Informatics|May 19, 2015
Prediction of early breast cancer metastasis from DNA microarray data using high-dimensional cox regression modelsChristophe Zemmour, François Bertucci, Pascal Finetti, et al.
Pharmaceutics|March 29, 2023
Prognostic and Predictive Value of <i>LIV1</i> Expression in Early Breast Cancer and by Molecular SubtypeAlexandre de Nonneville, Pascal Finetti, Laurys Boudin, et al.
Molecular Cancer|October 4, 2014
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterizationRenaud Sabatier, Pascal Finetti, Arnaud Guille, et al.
Briefings in Bioinformatics|January 19, 2025
A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencingArnaud Guille, José Adélaïde, Pascal Finetti, et al.
Breast Cancer Research and Treatment|July 28, 2011
Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agentsGais Kadra, Pascal Finetti, Yves Toiron, et al.
Genes, Chromosomes & Cancer|September 16, 2010
BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancerRenaud Sabatier, José Adélaïde, Pascal Finetti, et al.
Breast (Edinburgh, Scotland)|July 8, 2014
Genomic profiling of inflammatory breast cancer: a reviewFrançois Bertucci, Pascal Finetti, Peter Vermeulen, et al.
Pageof 18

Showing results (21-30 of 180) with videos related to

Sort By:
Pageof 18
International Journal of Cancer|April 10, 2008
How basal are triple-negative breast cancers?François Bertucci, Pascal Finetti, Nathalie Cervera, et al.
Cancers|September 5, 2020
Revisiting the Concept of Stress in the Prognosis of Solid Tumors: A Role for Stress Granules Proteins?Anaïs Aulas, Pascal Finetti, Shawn M Lyons, et al.
Oncoimmunology|July 9, 2015
PDL1 expression is an independent prognostic factor in localized GISTFrançois Bertucci, Pascal Finetti, Emilie Mamessier, et al.
Cancer Informatics|May 19, 2015
Prediction of early breast cancer metastasis from DNA microarray data using high-dimensional cox regression modelsChristophe Zemmour, François Bertucci, Pascal Finetti, et al.
Pharmaceutics|March 29, 2023
Prognostic and Predictive Value of <i>LIV1</i> Expression in Early Breast Cancer and by Molecular SubtypeAlexandre de Nonneville, Pascal Finetti, Laurys Boudin, et al.
Molecular Cancer|October 4, 2014
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterizationRenaud Sabatier, Pascal Finetti, Arnaud Guille, et al.
Briefings in Bioinformatics|January 19, 2025
A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencingArnaud Guille, José Adélaïde, Pascal Finetti, et al.
Breast Cancer Research and Treatment|July 28, 2011
Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agentsGais Kadra, Pascal Finetti, Yves Toiron, et al.
Genes, Chromosomes & Cancer|September 16, 2010
BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancerRenaud Sabatier, José Adélaïde, Pascal Finetti, et al.
Breast (Edinburgh, Scotland)|July 8, 2014
Genomic profiling of inflammatory breast cancer: a reviewFrançois Bertucci, Pascal Finetti, Peter Vermeulen, et al.
Pageof 18